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Abstract:
In this paper we use open-loop constrained non-linear optimal control to compute insulin
administration profiles for people with type 1 diabetes. The algorithm is a multiple shooting
algorithm based on sequential quadratic programming (SQP) for optimisation and an explicit
Dormand-Prince Runge-Kutta method (DOPRI54) for numerical integration and sensitivity
computation. We describe the numerical details of the constrained non-linear optimal control
algorithm. The Hovorka model is used to describe a person with type 1 diabetes. We use the
model and the algorithm to compute insulin administration profiles for people with type 1
diabetes in the cases with and without meal announcement in advance. The case with advance
meal announcement results in almost perfect glucose control, but is undesirable as an insulin
therapy due to the fact that most of the meal-related insulin is injected before the meal is
actually taken. In the second, more realistic case, information about the meal is provided to
the controller as the meal is taken. In this case, the optimal insulin administration profile is
characterised by bolus-like injections of insulin coincident with the meals. These results indicate
that, for certain conditions, insulin pens may be able to provide glucose control comparable to
that of insulin pumps.
Keywords: type 1 diabetes, non-linear model predictive control, meal announcement
1. INTRODUCTION
The World Health Organization (2009) estimates that 180
million people worldwide have diabetes. This number is
projected to double by 2030. In the USA, the budget for
diabetes represents approximately 10% of the health care
budget, i.e., more than 130 billion dollars.
People with type 1 diabetes produce negligible amounts
of pancreatic insulin. To maintain normal blood glucose
concentrations, or normoglycaemia (approximately 60–140
mg/dL or 3.3–7.8 mmol/L), exogenous insulin must be
injected. The glucose concentration must be regulated
around 90 mg/dL and kept in the normoglycaemic range
in order to avoid diabetes-related complications. Persis-
tent high blood glucose concentrations above 140 mg/dL
(hyperglycaemia) cause vascular, nerve, eye and kidney
diseases. On the other hand, very low blood glucose con-
centrations (hypoglycaemia) can cause insulin shock or
coma.
Insulin reduces the glucose concentration in the blood by
facilitating the uptake of glucose into liver cells, where
it can be stored as glycogen, and into peripheral tissue
cells (muscles and adipose), where it can be stored or
metabolised. Two types of insulin secretion patterns are
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used by a normal, fully functional pancreas. First, a low,
relatively constant basal rate of insulin is needed to coun-
teract the glucose secreted by the conversion of glycogen
to glucose in the liver (endogenous glucose production, or
EGP). In addition to EGP, the major disturbance affecting
the blood glucose levels is the absorption of carbohydrates
(CHO) from meals. To offset these large loads of glucose,
insulin is secreted in rapidly released boluses.
The challenge, then, for people with type 1 diabetes, is to
try to mimic these insulin delivery patterns of a normal
pancreas as closely as possible. Exogenous insulin therapy
is often based on several (say, 4–8) blood glucose mea-
surements per day, some of which are typically taken just
before meals. Rapid-acting insulin analogues are injected
as boluses to compensate for the CHO in the meal and
correct the current blood glucose level if necessary. Long-
acting insulin analogues are taken infrequently (say, once
per day) to counteract EGP. In well controlled subjects,
the outcome of this therapy is illustrated in Fig. 1. Fig.
1 shows the daily glucose concentration tracings for one
subject for seven consecutive days. Clearly, there is much
room for improvement in the degree of glucose control.
Significant parts of days are spent in the hyperglycaemic
range, and occasionally hypoglycaemic events do occur.
Digestion and absorption of CHO from the gastrointestinal
tract into the blood is generally faster than absorption of
Fig. 1. Glucose concentration variations in a person with
type 1 diabetes for 5 consecutive days using conven-
tional insulin therapy based on discrete glucose mea-
surements and discrete insulin injections. The green-
shaded area represents the normoglycaemic range.
Fig. 2. Closed-loop glucose control. Glucose is measured
subcutaneously using a continuous glucose monitor
(CGM). Insulin is dosed either continuously by an
insulin pump or discretely using an insulin pen.
subcutaneously injected insulin into the blood. Further-
more, the glucose-insulin dynamics are complex and non-
linear. Thus, with infrequent, discrete measurements of
blood glucose and estimates of the CHO content in meals,
it is not surprising that the degree of control depicted in
Fig. 1 is typical of conventional insulin therapy.
To improve the glycaemic control by fine-tuning their
insulin therapy, people with type 1 diabetes are using
continuous glucose monitors (CGMs) more prevalently.
These CGMs continuously (every one to few minutes) mea-
sure the subcutaneous glucose concentration. In addition,
insulin pumps that can continuously infuse rapid-acting
insulin are becoming more popular. The combination of
these two medical devices has inspired much research inter-
est in an artificial beta-cell (pancreas) that automatically
adjusts the insulin dosage to control the blood glucose in
people with type 1 diabetes. This concept is illustrated in
Fig. 2. Several research groups worldwide are investigating
aspects of control algorithms integrating the CGM and the
insulin pump to automatically adjust insulin administra-
tion for people with type 1 diabetes, such as Klonoff et al.
(2009).
The quality of the glucose control is limited by the time lag
associated with subcutaneous-to-intravenous insulin ab-
sorption. In some mathematical descriptions of the phys-
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Fig. 3. Diagram of the Hovorka model.
iology, such as that of Hovorka et al. (2004), the ab-
sorption and transport of subcutaneously injected insulin
to systemic circulation is modeled as linear second order
process with time constants of τS = 55 min. Digestion and
absorption of CHO is similarly modelled as a linear second
order process, but with time constants of τD = 40 min.
These absorption models and their relation to glucose-
insulin dynamics in the Hovorka model are illustrated
in Fig. 3. This system property fundamentally limits the
control quality that can be achieved in closed-loop insulin
administration.
In this paper, we use constrained non-linear optimal con-
trol theory to compute the optimal insulin injection rates
during a day. The computed profiles are open loop profiles
and are not based on feedback. We consider the case
when the meals throughout the day are announced to the
controller in advance, and the case when the meals are only
announced to the controller when they are taken. Knowing
the ideal insulin administration profiles, we compare and
discuss the advantages, disadvantages, and implications
of these solutions. In particular, we address the issue of
whether we can expect fundamentally better insulin ther-
apy with pumps than with pens in the limiting case of
perfect meal information.
The paper is structured as follows. The constrained non-
linear optimal control problem is presented in Section 2.
Section 3 presents an quasi-Newton SQP algorithm with
line search for solution of the discrete-time constrained
non-linear Bolza problem. The numerical procedures for
integration of the differential equations and computation
of their sensitivities are also presented in Section 3. The
non-linear model predictive controller and the scenarios
are stated in Section 4. Section 5 applies the constrained
non-linear optimal control algorithm to compute insulin
administration profiles for virtual subjects with type 1
diabetes. Conclusions are provided in Section 6.
2. PROBLEM FORMULATION
In this section, we state and discuss the continuous-time
optimal control problem that we use to compute the in-
sulin injection profiles for people with type 1 diabetes. We
also discuss a numerically tractable discrete-time approx-
imation to the continuous-time optimal control problem.
The bound constrained continuous-time Bolza problem
min
[x(t),u(t)]
tf
t0
φ =
∫ tf
t0
g(x(t), u(t))dt+ h(x(tf )) (1a)
s.t. x(t0) = x0 (1b)
x˙(t) = f(x(t), u(t), d(t)) t ∈ [t0, tf ]
(1c)
umin ≤ u(t) ≤ umax t ∈ [t0, tf ]
(1d)
is used to compute the optimal insulin administration.
x(t) ∈ Rnx is the state vector, u(t) ∈ Rnu is the manip-
ulated inputs, and d(t) ∈ Rnd are known disturbances.
x˙(t) = f(x(t), u(t), d(t)) represents the model equations.
The initial time, t0, and the final time, tf , are specified
parameters. The initial state, x0, is a known parameter in
(1). The inputs are bound constrained and must be in the
interval u(t) ∈ [umin, umax].
The objective function is stated generally with a stage cost
term, g(x(t), u(t)), and a cost-to-go term, h(x(tf )). The
numerical algorithms for the problem are derived using
this general structure of the objective function.
In the insulin administration problem, the stage cost term
is a penalty function, the cost-to-go term is zero, and the
model equations are represented by the Hovorka model
Hovorka et al. (2004). u(t) represents the rate of insulin
injection at any time and d(t) represents the carbohydrates
(CHO) intake rate at any time. Given an initial state, x0,
and a CHO intake rate profile, [d(t)]
tf
t0 , the continuous-time
Bolza problem (1) computes the optimal insulin injection
rate profile, [u(t)]
tf
t0 , as well as the optimal state trajectory,
[x(t)]
tf
t0 .
2.1 Discrete-Time Approximation
The continuous-time bound constrained Bolza problem (1)
is approximated by a numerical tractable discrete-time
bound constrained Bolza problem using the zero-order-
hold input parametrisation of the manipulated variables,
u(t), as well as the known disturbance variables, d(t).
We divide the time interval, [t0, tf ], into N equidistant
intervals each of length Ts. Let N = {0, 1, ..., N − 1} and
tk = t0 + kTs for k ∈ N . The zero-order-hold restriction
on the input variables, u(t) and d(t), imply
u(t) = uk tk ≤ t < tk+1 k ∈ N (2a)
d(t) = dk tk ≤ t < tk+1 k ∈ N (2b)
Using this zero-order-hold restriction on the inputs, the
bound constrained continuous-time Bolza problem may be
expressed as
min
{xk+1,uk}N−1k=0
φ =
N−1∑
k=0
Gk(xk, uk, dk) + h(xN ) (3a)
s.t. bk := Fk(xk, uk, dk)− xk+1 = 0 k ∈ N
(3b)
umin ≤ uk ≤ umax k ∈ N
(3c)
The discrete-time state transition function is
Fk(xk, uk, dk) = {x(tk+1) : x˙(t) = f(x(t), uk, dk), x(tk) = xk}
(4)
and the discrete time stage cost is
Gk(xk, uk, dk) = {
∫ tk+1
tk
g(x(t), uk)dt :
x˙(t) = f(x(t), uk, dk), x(tk) = xk}
(5)
3. NUMERICAL OPTIMISATION ALGORITHM
In this section, we develop a multiple-shooting based SQP
algorithm described in Diehl et al. (2009) and in Bock and
Plitt (1984) for the numerical solution of (1). The SQP
algorithm is based on line search. The structure of the
quadratic sub-problems are utilised and they are solved
by a primal-dual interior-point algorithm using Riccati
iterations, as in Jørgensen (2005) and Rao et al. (1998).
The DOPRI54 scheme derived in Dormand and Prince
(1980) is used for numerical solution of the differential
equation model and sensitivities.
3.1 SQP Algorithm
Define the parameter vector, p, as
p =
[
u′0 x
′
1 u
′
1 x
′
2 . . . x
′
N−1 u
′
N−1 x
′
N
]′
, (6)
and the disturbance vector, d =
[
d′0 d
′
1 . . . d
′
N−1
]′
, such
that the discrete time dynamics may be represented by
b(p) = b(p;x0, d) =

F0(x0, u0, d0)− x1
F1(x1, u1, d1)− x2
...
FN−1(xN−1, uN−1, dN−1)− xN

(7)
and the objective function may be denoted
φ(p) = φ(p;x0, d) =
N−1∑
k=0
Gk(xk, uk,d ) + h(xN ) (8)
Let c(p) denote the bound constraints, i.e.
c(p) =

u0 − umin
u1 − umin
...
uN−1 − umin
umax − u0
umax − u1
...
umax − uN−1

. (9)
Then the bound constrained discrete-time Bolza problem
may be expressed as a constrained optimisation problem
in standard form
min
p
φ = φ(p) (10a)
s.t. b(p) = 0 (10b)
c(p) ≥ 0 (10c)
The concise formulation (10) is useful for presentation of
the numerical optimisation algorithm used for solving the
bound constrained continuous-time Bolza problem (1).
The Lagrangian of (10) is
L(p, y, z) = φ(p)− y′b(p)− z′c(p) (12)
Algorithm 1 SQP Algorithm for (10)
Require: Initial guess: (p0, y0, z0) with z0 ≥ 0.
Compute: φ(p0),∇pφ(p0), b(p0),∇pb(p0), c(p0),∇pc(p0)
Set λ = 0, µ = 0, W 0 = I
while NOT stop do
Compute (∆pk, y˜k+1, z˜k+1) by solution of:
min
∆p
1
2
∆p′W k∆p+∇pφ′(pk)∆p (11a)
s.t.
[∇pb(pk)]′∆p = −b(pk) (11b)[∇pc(pk)]′∆p ≥ −c(pk) (11c)
Compute ∆yk = y˜k+1 − yk and ∆zk = z˜k+1 − zk
Update the penalty parameter:
µ← max{|z|, 12 (µ+|z|)} and λ← max{|y|, 12 (λ+|y|)}
Compute α using soft line search and Powell’s `1 merit
function (14).
pk+1 = pk + α∆pk, yk+1 = yk + α∆yk, zk+1 = zk +
α∆zk
Compute φ(pk+1),∇pφ(pk+1), c(pk+1), ∇pc(pk+1),
b(pk+1) and ∇pb(pk+1)
Compute W k+1 by Powell’s modified BFGS update.
k ← k + 1.
end while
and the first order KKT conditions
∇pL(p, y, z) = ∇pφ(p)−∇pb(p)y −∇pc(p)z = 0 (13a)
b(p) = 0 (13b)
c(p) ≥ 0 (13c)
z ≥ 0 (13d)
ci(p) = 0 ∨ zi = 0 ∀i (13e)
are used to test convergence of the SQP algorithm (Alg.
1).
The steps for solution of (10) by an SQP algorithm with
line search are listed in Algorithm 1. The line search is
based on Powell’s `1 penalty function
P (p) = φ(p) + λ′|b(p)|+ µ′|min{0, c(p)}| (14)
and the Armijo sufficient decrease condition. The penalty
vectors, λ and µ, are selected such that they are numeri-
cally larger than the corresponding Lagrange multipliers,
i.e. λ ≥ |y| and µ ≥ z where y is the Lagrange multipliers
associated with (10b) and z is the Lagrange multipliers
associated with (10c).
3.2 Gradient Computation
The most time consuming computations in Algorithm 1
are computation of the objective function φ(p), computa-
tion of the derivatives of the objective function ∇pφ(p),
computation of the dynamics b(p), and computation of
the sensitivities, ∇pb(p), associated with the dynamics.
b(p) and φ(p) are computed by evaluation of (4) and (5),
respectively. Consequently
bk = bk(xk, xk+1, uk, dk) = Fk(xk, uk, dk)− xk+1
(15a)
∇xkbk = ∇xkFk(xk, uk, dk) = Sxk(tk+1)′ = A′k (15b)
∇ukbk = ∇ukFk(xk, uk, dk) = Suk(tk+1)′ = B′k (15c)
∇xk+1bk = −I (15d)
where x(tk+1) = F (xk, uk, dk) and
x˙(t) = f(x(t), uk, dk) (16a)
S˙xk(t) =
(
∂f
∂x
(x(t), uk, dk)
)
Sxk(t) (16b)
S˙uk(t) =
(
∂f
∂x
(x(t), uk, dk)
)
Suk(t) +
(
∂f
∂u
(x(t), uk, dk)
)
(16c)
with the initial conditions x(tk) = xk, Sxk(tk) = I, and
Suk(tk) = 0. The stage cost and the associated derivatives
are computed as
Gk = Gk(xk, uk, dk) =
∫ tk+1
tk
g(x(t), uk, dk)dt (17a)
qk = ∇xkGk =
∫ tk+1
tk
(
∂g
∂x
(x(t), uk, dk)
)
Sxk(t)dt
(17b)
rk = ∇ukGk =
∫ tk+1
tk
[(
∂g
∂x
(x(t), uk, dk)
)
Suk(t)
+
(
∂g
∂u
(x(t), uk, dk)
)]
dt (17c)
The derivatives ∇xkbk and ∇xkGk are computed for
{xk}N−1k=1 and k ∈ N . These derivatives are not computed
for x0 as x0 /∈ p, i.e. x0 is a fixed parameter of the
optimisation problem but not a decision variable. The
derivatives ∇ukbk and ∇ukGk are computed for k ∈ N .
The derivatives with respect to xN are
∇xN bN−1 = −I (18a)
pN = ∇xNφ = ∇xNh(xN ) (18b)
In evaluation of the functions and derivatives needed in the
SQP algorithm, i.e. evaluation of φ(p), ∇pφ(p), b(p), and
∇pb(p), the major computational task is solution to the
differential equations (16) and evaluation of the associated
quadrature equations (17). The Hovorka model is a non-
stiff system of differential equations. Therefore, we use an
embedded Dormand-Prince explicit Runge-Kutta scheme
(DOPRI54) described in Dormand and Prince (1980) for
solution of the differential equations (16) and integration
of the quadrature equations (17). The Butcher tableau (see
Butcher (2003)) of the DOPRI54 method is listed in Table
1. The DOPRI54 method has 7 stages, the advancing step,
x, has order 5, and the error estimator, e, has order 4.
A special DOPRI54 method tailored for solution of (16)-
(17) has been implemented. In this implementation, we
re-use the internal stages computed by solution of (16)
in the evaluation of the quadrature equation (17). The
implementation uses an adaptive time step based on PI-
control developed by Gustafsson (1992).
When p is given as in the multiple shooting algorithm,
evaluation of c(p) and ∇pc(p) becomes trivial. As c(p)
represents the bound constraints, umin ≤ uk ≤ umax
for k ∈ N , ∇pc(p) is a constant and the corresponding
constraints in the quadratic program (11) become bound
constraints as well.
4. APPLICATION TO AN ARTIFICIAL PANCREAS
In this section we state and discuss the objective function
and the scenarios used in the simulations. We also state
the strategy for the non-linear model predictive controller.
Table 1. Butcher tableau for the DOPRI54
method.
0 0 0 0 0 0 0 0
1
5
1
5
0 0 0 0 0 0
3
10
3
40
9
40
0 0 0 0 0
4
5
44
55
−56
15
32
9
0 0 0 0
8
9
19372
6561
−25360
2187
64448
6561
−212
729
0 0 0
1 9017
3168
−355
33
46732
5247
49
176
−5103
18656
0 0
1 35
384
0 500
1113
125
192
−2187
6784
11
84
0
x 5179
57600
0 7571
16695
393
640
−92097
339200
187
2100
1
40
xˆ 35
384
0 500
1113
125
192
−2187
6784
11
84
0
e 71
57600
0 −71
16695
71
1920
−17253
339200
22
525
−1
40
4.1 Non-linear Model Predictive Control (NMPC)
NMPC is a receding horizon control technology that re-
peatedly solves open-loop non-linear optimal control prob-
lems and implements the computed optimal control asso-
ciated to the current time period (see e.g. Rawlings and
Mayne (2009)). In this contribution, we use a receding
horizon strategy to compute the ideal insulin adminis-
tration profile for people with type 1 diabetes. In order
to obtain the ideal insulin profile, the NMPC uses state
feedback and relative long prediction horizons.
4.2 Objective Function with Soft Output Constraints
The objective of the insulin administration is to compen-
sate glucose excursions caused by meals and variations in
endogenous glucose production and utilisation. We use a
penalty function defined as
ρ(G(t)) =
κ1
2
|max{0, G(t)− G¯}|2
+
κ2
2
|max{0, G¯−G(t)}|2
+
κ3
2
|max {0, G(t)−GU}|2
+
κ4
2
|max {0, GL −G(t)}|2
(19)
G(t) is the blood glucose concentration, G¯ = 5 mmol/L
is the target value for the blood glucose concentration,
GL = 4 mmol/L is a lower acceptable limit on the glucose
concentration, and GU = 8 mmol/L is an upper acceptable
limit on the blood glucose concentration. The weights
κ1-κ4 are used to balance the desirability of different
deviations from the target. As hypoglycaemia is considered
worse than hyperglycaemia, κ1 < κ2 and κ3 < κ4. The
penalty function used in the simulations is illustrated
in Fig. 4. G(t) is a function of the state, x(t), in the
Hovorka model. Therefore, the penalty function (19) may
be expressed as a stage cost in the form g(x(t), u(t)). The
objective function used in the simulations is
φ =
∫ tf
t0
g(x(t), u(t))dt+
η
2
N−1∑
k=0
‖∆uk‖22 (20)
where ∆uk = uk − uk−1. This objective function has no
cost-to-go function, i.e. h(x(tf )) = 0, and can be brought
into the standard form (3a) using state augmentation
formulated by Rawlings and Mayne (2009).
We use umin = 0 and a large umax such that the upper
bound is never active. We do the optimisation in a 24
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Fig. 4. Penalty as a function of the blood glucose con-
centration. The green shaded area is an interval of
acceptable glucose concentrations. The target glucose
concentration is 5 mmol/L. Blood glucose concen-
trations less than 3 mmol/L is very undesirable as
people may fall into coma at this low blood glucose
concentration.
hour window, i.e. t0 = 0 min and tf = 24 · 60 min, using a
sampling time of Ts = 5 min. In the scenario considered,
the simulated 70 kg subject has a 62 g CHO meal at 6:00,
a 55 g CHO meal at 12:00, and a 50 g CHO meal at 18:00.
To ensure an optimal blood glucose profile, a prediction
horizon of six hours, i.e., N = 6 · 12 = 72 samples, is
employed in the receding horizon strategy.
5. SIMULATION RESULTS
In this Section, we use the model developed by Hovorka
et al. (2004) and the developed multiple shooting SQP al-
gorithm for (1) to compute insulin administration profiles
for people with type 1 diabetes.
Fig. 5 illustrates an optimal insulin administration profile
for the described scenario in the case where the controller
knows the size and time of all meals in advance. Knowing
the meal times and sizes allows the controller to deliver
anticipatory insulin to pre-empt postprandial hypergly-
caemia. However, the assumption that the patient would
know in advance - and with accuracy - the meal times and
sizes is not practical. Safety considerations would preclude
significant amounts of insulin from being delivered prior to
mealtime (as in this ideal scenario).
Fig. 6 shows the simulation results for the case in which
the meals are announced to the MPC only at mealtime.
Thus, the controller can deliver no anticipatory insulin
prior to meals. The limitations for this case force the
subject into (mild) hyperglycaemia, but hypoglycaemia
is avoided. The insulin delivery profile for this case looks
quite similar to bolus delivery of insulin by a pen; most of
the meal-related insulin is delivered in bolus form in the
few samples after the meals are taken (and announced).
Simulated optimal bolus treatment with a pen provides
glucose profiles comparable to the glucose profile in Fig.
6.
Fig. 5. Glucose profile (top), meal disturbances (middle)
and optimal insulin administration profile (bottom)
for the case with meal announcement in advance of
the meal. Most insulin is taken before the meals.
Fig. 6. Glucose profile (top), meal disturbances (middle)
and optimal insulin administration profile (bottom)
with meal announcement at meal time. Most insulin
is taken in bolus like form at meal time.
These results demonstrate that for realistic cases, i.e.,
cases for which meal information is unknown until meal-
time, reasonably good control can still be obtained. Per-
haps more importantly, the bolus like nature of the insulin
profile in this case suggests that a pen-based system may
be able to achieve control comparable to that of a pump.
6. CONCLUSION
In this paper, we described a multiple shooting SQP
algorithm for solution of a bound constrained continuous-
time Bolza problem. Based on the model developed by
Hovorka et al. (2004) for people with type 1 diabetes,
we use our optimal control algorithm to compute insulin
administration profiles for the cases with and without
meal announcement in advance. The insulin profile for the
realistic case with announcement of meals at mealtime is
bolus like. This suggests that insulin treatment based on
pen-systems may be nearly as effective as insulin treatment
based on pump systems.
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